Unichem Laboratories Ltd.
NSE: UNICHEMLAB | BSE: 506690
₹595.60
₹6.55
(1.11%)
As on 20-Jul-2026IST
Market cap
₹4,189 Cr
Revenue (TTM)
₹2,202 Cr
P/E Ratio
16.6
P/B Ratio
1.5
Div. Yield
0 %
Quality Score
1/10
Growth Score
6/10
Valuation Score
3/10
Momentum Score
8/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹253 Cr
-
ROE
9.8 %
-
ROCE
10.7 %
-
Industry P/E
54.38
-
EV/EBITDA
17.6
-
Debt to Equity
0.2
-
Book Value
₹385.2
-
EPS
₹35.9
-
Face value
2
-
Shares outstanding
70,405,751
10 Years Aggregate
CFO
₹-653.21 Cr
EBITDA
₹346.66 Cr
Net Profit
₹-127.80 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Unichem Lab
| 34.8 | 34.1 | 69.6 | -5.1 | 16.4 | 11.9 | 6.9 |
|
BSE Healthcare
| 15.9 | 5.2 | 15.8 | 11.6 | 23.9 | 13.8 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Unichem Lab
| -39.9 | 80.0 | 28.6 | 26.9 | -4.5 | 62.0 | -16.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Unichem Lab
|
595.6 | 4,189.1 | 2,201.9 | 252.8 | 2.5 | 9.8 | 16.6 | 1.5 |
| 1,132.3 | 13,915.0 | 2,551.8 | 564.5 | 28.3 | 18.4 | 24.7 | 4.2 | |
| 589.5 | 11,162.5 | 947.3 | 247.8 | 28.5 | 18.9 | 45 | 5.2 | |
| 1,335.0 | 13,942.2 | 1,054.9 | 259.2 | 27.8 | 13.5 | 53.4 | 6.9 | |
| 1,861.2 | 35,293.8 | 9,203.5 | 941.3 | 15.4 | 19.6 | 38.2 | 7.1 | |
| 18,949.0 | 24,302.4 | 2,023.0 | 364.0 | 23.9 | 21.4 | 66.8 | 13.0 | |
| 1,046.6 | 5,309.8 | 811.3 | 21.0 | 0.7 | 2.1 | 258.4 | 4.1 | |
| 1,385.0 | 6,382.6 | 649.5 | 121.6 | 23.7 | 13.2 | 55.3 | 6.8 | |
| 866.5 | 9,780.8 | 642.3 | 174.3 | -- | 25.4 | 56.6 | 11.1 | |
| 338.5 | 9,573.2 | 7.1 | -276.3 | -4,077.5 | -63.3 | -- | 11.4 |
Shareholding Pattern
View DetailsNews & Analysis
All News
Are these companies really bargains?
2 min read•By Danish Khanna
Top contrary bets by FIIs and DIIs
5 min read•By Rajan Gulati
2 min read•By Yash Rohra
2 min read•By Value Research
4 min read•By Anindya Bera
2 min read•By Research Desk
About Unichem Lab
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in India, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as... gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. It serves patients, distributors, health care professionals, and government institutions. The company was founded in 1944 and is based in Mumbai, India. Unichem Laboratories Limited is a subsidiary of Ipca Laboratories Limited. Read more
-
Incorporated
1962
-
Chairman
Prakash A Mody
-
Managing Director
Pabitrakumar Kalipada Bhattacharyya
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Unichem Laboratories Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Unichem Lab
What is the current share price of Unichem Laboratories Ltd Today?
The share price of Unichem Laboratories Ltd is ₹595.60 (NSE) and ₹595.00 (BSE) as of 20-Jul-2026 IST. Unichem Laboratories Ltd has given a return of 16.44% in the last 3 years.
What is the current PB & PE ratio of Unichem Laboratories Ltd?
The P/E ratio of Unichem Laboratories Ltd is 16.57 times as on 20-Jul-2026, a 70 discount to its peers’ median range of 54.38 times.
The P/B ratio of Unichem Laboratories Ltd is 1.54 times as on 20-Jul-2026, a 63 discount to its peers’ median range of 4.15 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2026
|
8.18
|
0.76
|
|
2025
|
35.47
|
1.99
|
|
2024
|
0.00
|
1.41
|
|
2023
|
0.00
|
0.84
|
|
2022
|
55.44
|
0.70
|
What is the 52 Week High and Low of Unichem Laboratories Ltd?
The 52-week high and low of Unichem Laboratories Ltd are Rs 687.20 and Rs 278.20 as of 21-Jul-2026.
What is the market cap of Unichem Laboratories Ltd?
Unichem Laboratories Ltd has a market capitalisation of ₹ 4,189 Cr as on 20-Jul-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Unichem Laboratories Ltd?
Before investing in Unichem Laboratories Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.